Impact of Nanotechnology on Glioblastoma Studies: From Brain Stem Cells to Neoplastic Development and Cancer Gene Therapy
{{output}}
The brain malignant tumor Glioblastoma multiforme (GBM) has a median survival of 14-16 months using current treatments; thus, understanding the pathology of GBM is crucial for proposing new therapies and increasing overall survival outcomes. Therefore, this st... ...
